DK1054868T3 - Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi - Google Patents

Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi

Info

Publication number
DK1054868T3
DK1054868T3 DK99934281T DK99934281T DK1054868T3 DK 1054868 T3 DK1054868 T3 DK 1054868T3 DK 99934281 T DK99934281 T DK 99934281T DK 99934281 T DK99934281 T DK 99934281T DK 1054868 T3 DK1054868 T3 DK 1054868T3
Authority
DK
Denmark
Prior art keywords
pyridinoarylpiperazines
substituted
treatment
prostate hyperplasia
hyperplasia
Prior art date
Application number
DK99934281T
Other languages
Danish (da)
English (en)
Inventor
Gee-Hong Kuo
William V Murray
Catherine P Prouty
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1054868T3 publication Critical patent/DK1054868T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK99934281T 1998-02-20 1999-02-19 Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi DK1054868T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
DK1054868T3 true DK1054868T3 (da) 2003-12-22

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934281T DK1054868T3 (da) 1998-02-20 1999-02-19 Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi

Country Status (23)

Country Link
US (1) US6218396B1 (enExample)
EP (1) EP1054868B1 (enExample)
JP (1) JP2002503724A (enExample)
KR (1) KR100591028B1 (enExample)
CN (1) CN1121390C (enExample)
AR (1) AR014626A1 (enExample)
AT (1) ATE250580T1 (enExample)
AU (1) AU766398B2 (enExample)
BR (1) BR9909647A (enExample)
CZ (1) CZ294136B6 (enExample)
DE (1) DE69911582T2 (enExample)
DK (1) DK1054868T3 (enExample)
ES (1) ES2209468T3 (enExample)
HU (1) HUP0100781A3 (enExample)
IL (2) IL137954A0 (enExample)
NO (1) NO317103B1 (enExample)
NZ (1) NZ506462A (enExample)
PL (1) PL342339A1 (enExample)
PT (1) PT1054868E (enExample)
TR (1) TR200003220T2 (enExample)
TW (1) TW565555B (enExample)
WO (1) WO1999042448A1 (enExample)
ZA (1) ZA991315B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269807C (zh) * 1997-05-12 2006-08-16 奥索-麦克尼尔药品公司 可用于治疗良性前列腺肥大的芳基取代哌嗪
ES2282279T3 (es) 2000-08-08 2007-10-16 Ortho-Mcneil Pharmaceutical, Inc. No-imidazol ariloxipiperidina como ligandos del receptor h3.
JP3878178B2 (ja) * 2001-12-28 2007-02-07 武田薬品工業株式会社 排尿障害予防治療剤
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
MX2010011652A (es) * 2008-04-23 2010-12-06 Takeda Pharmaceutical Derivados de iminopiridina y uso de los mismos.
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives

Also Published As

Publication number Publication date
JP2002503724A (ja) 2002-02-05
CN1121390C (zh) 2003-09-17
EP1054868A1 (en) 2000-11-29
AU766398B2 (en) 2003-10-16
IL137954A0 (en) 2001-10-31
DE69911582D1 (de) 2003-10-30
US6218396B1 (en) 2001-04-17
CZ20003044A3 (cs) 2001-04-11
NO20004141L (no) 2000-10-19
HUP0100781A2 (hu) 2001-08-28
ZA991315B (en) 2000-11-20
AR014626A1 (es) 2001-03-28
TW565555B (en) 2003-12-11
WO1999042448A1 (en) 1999-08-26
TR200003220T2 (tr) 2001-04-20
HK1030776A1 (en) 2001-05-18
CN1291188A (zh) 2001-04-11
IL137954A (en) 2007-06-03
KR20010041115A (ko) 2001-05-15
NZ506462A (en) 2003-07-25
CZ294136B6 (cs) 2004-10-13
ES2209468T3 (es) 2004-06-16
BR9909647A (pt) 2000-11-21
ATE250580T1 (de) 2003-10-15
NO20004141D0 (no) 2000-08-18
AU3302599A (en) 1999-09-06
KR100591028B1 (ko) 2006-06-22
PL342339A1 (en) 2001-06-04
EP1054868B1 (en) 2003-09-24
HUP0100781A3 (en) 2002-12-28
DE69911582T2 (de) 2005-09-15
PT1054868E (pt) 2004-01-30
NO317103B1 (no) 2004-08-09

Similar Documents

Publication Publication Date Title
DK1077940T3 (da) 4-Phenylpiperidiner til behandling af pruritiske dermatoser
DK1292594T3 (da) Quinazolinderivater til behandling af tumorer
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK0830864T3 (da) Kombinationsbehandling til behandling af psykoser
DK0942754T3 (da) Konjugater anvendelige til behandlingen af prostatacancer
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1028954T3 (da) Substituerede imidazoler egnede til behandling af inflammatoriske sygdomme
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DE69938817D1 (de) Erstellungsverfahren
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
ID29021A (id) Komposisi galantamina pelepasan terkontrol
FI20000863A0 (fi) Uusi hoitomenetelmä
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
DK199800837A (da) Anlæg til behandling af emner
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
DK0965566T3 (da) Fremgangsmåde til behandling af organisk spildevand
DK1054868T3 (da) Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi
NO20010456D0 (no) Triazolopyridiner for behandling av trombose-problemer
DK1008558T3 (da) Fremgangsmåde til behandling af organisk spildevand
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DK0948888T3 (da) System til behandling af gødning